Chlamydia pneumoniae activates IKK/IκB-mediated signaling, which is inhibited by 4-HNE and following primary exposure
- 30 November 2002
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 165 (1) , 79-88
- https://doi.org/10.1016/s0021-9150(02)00198-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Survival ofChlamydia pneumoniae-Infected Mono Mac 6 Cells Is Dependent on NF-κB Binding ActivityInfection and Immunity, 2001
- The IKK complex: an integrator of all signals that activate NF-κB?Trends in Cell Biology, 2000
- Phosphorylation Meets Ubiquitination: The Control of NF-κB ActivityAnnual Review of Immunology, 2000
- Chlamydia pneumoniae in atherosclerosisJournal of Internal Medicine, 2000
- Cellular Oxidation of Low‐Density Lipoprotein byChlamydia pneumoniaeThe Journal of Infectious Diseases, 1999
- Differential Effects of Lipopolysaccharide and Tumor Necrosis Factor on Monocytic IκB Kinase Signalsome Activation and IκB ProteolysisPublished by Elsevier ,1999
- Oxidized LDL and AtherogenesisaAnnals of the New York Academy of Sciences, 1999
- 4-Hydroxynonenal Prevents NF-κB Activation and Tumor Necrosis Factor Expression by Inhibiting IκB Phosphorylation and Subsequent ProteolysisJournal of Biological Chemistry, 1999
- Dysregulation of Monocytic Nuclear Factor-κB by Oxidized Low-Density LipoproteinArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- NF-κB: A lesson in family valuesCell, 1995